Ticker gaining positive sentiment over the weekend. FDA approval expected in Sept. after previously submitted positive Phase 3 results. Current PPS shows minimum R/R Ratio of 2.71. Will be looking to open half position swing entry at $2.20 and completing fill > $2.90.